• Biomarkers monitoring synaptic degeneration/loss would be valuable for Alzheimer's disease (AD) diagnosis. Postsynaptic protein neurogranin may be a promising cerebrospinal fluid (CSF) biomarker but has not yet been evaluated as a plasma biomarker.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Neurogranin

CSF biomarker

Plasma biomarker

Prognostic biomarker

Alzheimer's disease

Mild cognitive impairment

tau

Amyloid

γ-secretase

ELISA

Ratio amyloid β

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)